Tiziana Life Sciences (LON:TILS) Share Price Crosses Above Fifty Day Moving Average of $58.50

Tiziana Life Sciences PLC (LON:TILSGet Rating) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 58.50 ($0.71) and traded as high as GBX 59 ($0.71). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.71), with a volume of 297,127 shares traded.

Tiziana Life Sciences Trading Up 8.3 %

The stock has a market cap of ¬£113.85 million and a PE ratio of -3.59. The company has a quick ratio of 6.41, a current ratio of 6.54 and a debt-to-equity ratio of 2.36. The business’s fifty day moving average is GBX 58.50 and its 200 day moving average is GBX 58.50.

About Tiziana Life Sciences

(Get Rating)

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.

Featured Stories

Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.